Hypertension trials recruiting in Georgia

All Hypertension trials nationally

Cities in Georgia

Recruiting trials in Georgia

• A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study
  NCT07661329 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Morrow, Roswell
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Augusta, Austell, Brunswick
• A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
  NCT07222917 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta
• A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
  NCT06267274 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Morrow
• A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
  NCT07142356 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Georgia: Lawrenceville, Peachtree Corners
• A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
  NCT06822738 · Phase: Phase 3 · Ages: 45 Years and older · Sex: All (male and female) · Georgia: Roswell
• A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran
  NCT07553442 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Georgia: Savannah
• A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
  NCT07610278 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Georgia: Canton
• A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
  NCT06649110 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · Georgia: Atlanta
• Bioenergetic Effect of Pioglitazone in CLD-PH
  NCT06336798 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta
• Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
  NCT05401357 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Morrow, Roswell
• BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
  NCT06059638 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Marietta
• Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
  NCT05937854 · Phase: Phase 2 · Ages: 35 Years to 89 Years · Sex: All (male and female) · Georgia: Decatur
• Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
  NCT06402968 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · Georgia: Augusta, Marietta
• De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
  NCT05213676 · Phase: Phase 4 · Ages: 0 Months to 1 Month · Sex: All (male and female) · Georgia: Atlanta
• DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
  NCT06388421 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Columbus
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Columbus, Johns Creek, Lawrenceville, Macon
• Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension
  NCT06526858 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 80 Years · Sex: All (male and female) · Georgia: Atlanta
• Effects of an Antioxidant Supplement on Blood Vessel Health
  NCT06424756 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Georgia: Athens
• Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
  NCT07090161 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Georgia: Columbus
• Global Paradise System US Post Approval Study
  NCT06297291 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Marietta
• IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
  NCT06218355 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · Georgia: Atlanta
• LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
  NCT07288398 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Georgia: Athens, Atlanta
• Neurovascular Transduction During Exercise in Chronic Kidney Disease
  NCT02947750 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Georgia: Atlanta, Decatur
• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
  NCT06274801 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Georgia: Atlanta
• Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
  NCT07221279 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years and older · Sex: All (male and female) · Georgia: Kennesaw
• Pulmonary Hypertension Association Registry
  NCT04071327 · Phase: Not specified · Ages: 0 Years and older · Sex: All (male and female) · Georgia: Atlanta
• SPYRAL GEMINI Pilot Study
  NCT06907147 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Georgia: Atlanta
• Sisters for Heart Health: A Community Health Worker Initiative for Improving Heart Health in Farmworker Women
  NCT07111026 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 50 Years · Sex: Female · Georgia: Ellenton
• Technology-enabled Management Versus Usual Care for Blood Pressure
  NCT05479461 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 90 Years · Sex: All (male and female) · Georgia: Atlanta, Eatonton
• To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
  NCT06343298 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Georgia: Acworth, Peachtree Corners
• Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
  NCT06526195 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Augusta, Marietta
• Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure
  NCT06735599 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 65 Years · Sex: All (male and female) · Georgia: Atlanta
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
  NCT07181109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Brunswick, Canton, Columbus